Clinical Study
Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax
Table 3
AEs of CQ and PQ in the four groups.
| PQ regimens | Group A (no PQ) | Group B (15 mg/day × 14 days) | Group C (30 mg/day × 7 days) | Group D (30 mg/day × 14 days) |
| Number of patients enrolled | 397 | 398 | 381 | 380 | AEs of CQ* | 1 | 0 | 4 | 4 | Drop outs (discontinuation of CQ) due to CQ AEs | 0 | 0 | 0 | 1 | AEs of PQ** | 3 | 5 | 10 | 13 | Drop outs (discontinuation of PQ) due to PQ AEs*** | 0 | 2 | 2 | 7 | Total drop outs due to AEs (CQ and PQ)**** | None | 2 | 2 | 8 |
|
|
, , , .
|